223 related articles for article (PubMed ID: 28033528)
1. Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.
Applebaum MA; Vaksman Z; Lee SM; Hungate EA; Henderson TO; London WB; Pinto N; Volchenboum SL; Park JR; Naranjo A; Hero B; Pearson AD; Stranger BE; Cohn SL; Diskin SJ
Eur J Cancer; 2017 Feb; 72():177-185. PubMed ID: 28033528
[TBL] [Abstract][Full Text] [Related]
2. Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
Applebaum MA; Henderson TO; Lee SM; Pinto N; Volchenboum SL; Cohn SL
Pediatr Blood Cancer; 2015 Jan; 62(1):128-33. PubMed ID: 25251613
[TBL] [Abstract][Full Text] [Related]
3. Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
Martin A; Schneiderman J; Helenowski IB; Morgan E; Dilley K; Danner-Koptik K; Hatahet M; Shimada H; Cohn SL; Kletzel M; Hijiya N
Pediatr Blood Cancer; 2014 Aug; 61(8):1350-6. PubMed ID: 24634399
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine.
Huibregtse KE; Vo KT; DuBois SG; Fetzko S; Neuhaus J; Batra V; Maris JM; Weiss B; Marachelian A; Yanik GA; Matthay KK
Eur J Cancer; 2016 Oct; 66():144-52. PubMed ID: 27573428
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
7. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
8. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
10. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry.
Haupt R; Garaventa A; Gambini C; Parodi S; Cangemi G; Casale F; Viscardi E; Bianchi M; Prete A; Jenkner A; Luksch R; Di Cataldo A; Favre C; D'Angelo P; Zanazzo GA; Arcamone G; Izzi GC; Gigliotti AR; Pastore G; De Bernardi B
J Clin Oncol; 2010 May; 28(14):2331-8. PubMed ID: 20351331
[TBL] [Abstract][Full Text] [Related]
11. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors.
Peterson KM; Shao C; McCarter R; MacDonald TJ; Byrne J
Pediatr Blood Cancer; 2006 Jul; 47(1):83-8. PubMed ID: 16317732
[TBL] [Abstract][Full Text] [Related]
12. An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome?
Archer NM; Amorim RP; Naves R; Hettmer S; Diller LR; Ribeiro KB; Rodriguez-Galindo C
Pediatr Blood Cancer; 2016 Feb; 63(2):196-201. PubMed ID: 26193998
[TBL] [Abstract][Full Text] [Related]
13. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
Borgmann A; Zinn C; Hartmann R; Herold R; Kaatsch P; Escherich G; Möricke A; Henze G; von Stackelberg A;
Eur J Cancer; 2008 Jan; 44(2):257-68. PubMed ID: 17981026
[TBL] [Abstract][Full Text] [Related]
14. Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma.
Federico SM; Allewelt HB; Spunt SL; Hudson MM; Wu J; Billups CA; Jenkins J; Santana VM; Furman WL; McGregor LM
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e6-e12. PubMed ID: 24633303
[TBL] [Abstract][Full Text] [Related]
15. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
16. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
17. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
18. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
[TBL] [Abstract][Full Text] [Related]
19. Second malignant neoplasms after childhood cancer: A nationwide population-based study in Korea.
Ju HY; Moon EK; Lim J; Park BK; Shin HY; Won YJ; Park HJ
PLoS One; 2018; 13(11):e0207243. PubMed ID: 30440007
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study.
Friedman DN; Goodman PJ; Leisenring WM; Diller LR; Cohn SL; Howell RM; Smith SA; Tonorezos ES; Wolden SL; Neglia JP; Ness KK; Gibson TM; Nathan PC; Weil BR; Robison LL; Oeffinger KC; Armstrong GT; Sklar CA; Henderson TO
J Clin Oncol; 2023 Mar; 41(8):1565-1576. PubMed ID: 36525618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
